drugset / Trial / NCT01160289
A Study of LY900010 in Erectile Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of the study is to compare the efficacy of LY2452473 + tadalafil to tadalafil alone in improving the erectile function (EF) of men with erectile dysfunction (ED) who incompletely respond to tadalafil alone.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2452473 | Small molecule | 1 mg | Oral |
| Subject | LY2452473 | Small molecule | 5 mg | Oral |
| Subject | Tadalafil | Small molecule | 5 mg | Oral |
| Subject | Tadalafil | Small molecule | 10 mg | Oral |